RSV vaccine with added boost proves effective against new variants
Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…
New CDC dashboards track hospitalizations for COVID-19, flu, RSV
Editor's Note The Centers for Disease Control and Prevention (CDC) is hosting a new dashboard—Respiratory Virus Hospitalization Surveillance Network (RESP-NET)—that tracks hospitalization rates for laboratory-confirmed COVID-19, influenza, and Respiratory Syncytial Virus (RSV) by age, sex, race/ethnicity, state, and season. The information is based on data from a network of acute…
Rise in child RSV cases may cause hospital capacity strain in the winter
Editor's Note A “sharp rise” in cases of respiratory syncytial virus (RSV) this fall is worrying staff at US hospitals, who fear what may happen to the capacity of hospitals and other healthcare facilities if RSV, influenza, and COVID-19 infections peak around the same time this winter, The Washington Post…
Free Daily News
- Accreditation 360: Adjustments and opportunities
- CMS Rural Health Transformation funding announced for all 50 states
- Duke Health updates visitor guidelines due to respiratory illness spread
- Tri-City Cardiology ASC surpasses 6,000 procedures
- Study details impacts on hospital that moved total joints surgeries to ASC
- How can AI make your ASC more efficient and profitable?
- Break Barriers to Effective Communication in the OR
- Study Links Home-based Hip Fracture Recovery Success to Neighborhood Conditions
- Solventum Completes Acquisition of Wound Care Innovator Acera Surgical
- Wellness-centered leadership playbook released